Because it is difficult to estimate the future value of research and development, FASB requires that research and development costs be treated asMultiple choice question.a liability on the balance sheet.an asset on the balance sheet.a contra asset on the balance sheet.an expense on the income statement.

The FASB requires research and development costs to be expensed becauseMultiple choice question.research and development costs have no future value.it is difficult to objectively determine the future benefits.the costs of research are greater than the benefits.

How should research costs related to the development of an intangible asset be treated?Group of answer choicesExpensed as incurredIncluded in the cost of the assetAmortizedCapitalized

An accountant is required to make choices in measuring the value of:development expenditureall of the options listedinventoryproperty, plant, and equipment

The research and development (R&D) team at a pharmaceutical company is developing a drug for colon cancer. Which of the following is true of the R&D costs incurred in developing this drug during the current year?Multiple ChoiceThey are expensed in the period in which benefits from R&D accrue.They are treated in the same manner as intangible assets that are purchased.They are recorded as an intangible asset in the balance sheet.They are expensed directly in the income statement.

The process of allocating the cost of an asset to expense over the useful life of the asset is calledMultiple choice question.contra accounting.book value.depreciation.asset valuation.